Dr. Hönle AG provided earnings guidance for 2022. For the period the company announced that the board expects the Hönle Group to generate sales revenues of EUR 130 million to 140 million and an operating result (EBIT) of EUR 14 million to 17 million in financial year 2021/2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.9 EUR | 0.00% | +1.80% | +12.86% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.86% | 131M | |
+17.14% | 86.87B | |
+18.73% | 70.3B | |
+23.49% | 38.41B | |
+27.14% | 35.39B | |
+9.12% | 28.13B | |
+9.72% | 27.78B | |
+4.63% | 27.14B | |
+21.77% | 25.57B | |
+9.30% | 24.11B |
- Stock Market
- Equities
- HNL Stock
- News Dr. Hönle AG
- Dr. Hönle Ag Provides Earnings Guidance for 2022